These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11839623)

  • 1. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention.
    Chan AW; Bhatt DL; Chew DP; Quinn MJ; Moliterno DJ; Topol EJ; Ellis SG
    Circulation; 2002 Feb; 105(6):691-6. PubMed ID: 11839623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favourable effect of statin therapy on early survival benefit at the time of percutaneous coronary intervention for ST-elevation myocardial infarction and shock.
    Garot P; Bendaoud N; Lefèvre T; Morice MC
    EuroIntervention; 2010 Aug; 6(3):350-5. PubMed ID: 20884413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of preprocedural statin therapy on clinical outcomes for patients with stable coronary artery disease after percutaneous coronary interventions.
    Ko DT; Wijeysundera HC; Yun L; Austin PC; Cantor WJ; Tu JV
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):459-66. PubMed ID: 21712520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.
    Furukawa Y; Taniguchi R; Ehara N; Ozasa N; Haruna Y; Saito N; Doi T; Hoshino K; Shizuta S; Morimoto T; Imai Y; Teramukai S; Fukushima M; Kita T; Kimura T;
    Circ J; 2008 Dec; 72(12):1937-45. PubMed ID: 18948669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
    Perera D; Crake T; Lee V
    Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials.
    Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal of statins increases event rates in patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD;
    Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of statin therapy on clinical outcomes after acute myocardial infarction in patients with advanced renal dysfunction: A propensity score-matched analysis.
    Kim JS; Kim W; Park JY; Woo JS; Lee TW; Ihm CG; Kim YG; Moon JY; Lee SH; Jeong MH; Jeong KH;
    PLoS One; 2017; 12(8):e0183059. PubMed ID: 28806769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
    Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
    Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early effects of statins in patients with coronary artery disease and high C-reactive protein.
    Muhlestein JB; Anderson JL; Horne BD; Carlquist JF; Bair TL; Bunch TJ; Pearson RR;
    Am J Cardiol; 2004 Nov; 94(9):1107-12. PubMed ID: 15518602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J; Haider A; Swaminathan RV; Kim LK; Minutello RM; Bergman G; Wong SC; Feldman DN
    Am J Cardiol; 2012 Nov; 110(10):1397-404. PubMed ID: 22858186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statins and white blood cell count on mortality in patients with ischemic left ventricular dysfunction undergoing percutaneous coronary intervention.
    Lipinski MJ; Martin RE; Cowley MJ; Goudreau E; Malloy WN; Johnson RE; Vetrovec GW
    Clin Cardiol; 2006 Jan; 29(1):36-41. PubMed ID: 16477776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low incidence of cardiac events in statin-administered patients in CAG study.
    Saeki T; Sakuma N; Hayakawa K; Itou K; Wakami K; Tamai N; Kimura G
    J Atheroscler Thromb; 2009 Jun; 16(3):172-8. PubMed ID: 19556725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic statin therapy on clinical presentation and underlying lesion morphology in patients undergoing percutaneous intervention: an ADAPT-DES IVUS substudy.
    Kadohira T; Mintz GS; Souza CF; Witzenbichler B; Metzger DC; Rinaldi MJ; Mazzaferri EL; Duffy PL; Weisz G; Stuckey TD; Brodie BR; Crowley A; Kirtane AJ; Stone GW; Maehara A
    Coron Artery Dis; 2017 May; 28(3):218-224. PubMed ID: 28240675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of inflammation and benefit of statins after percutaneous coronary interventions.
    Chan AW; Bhatt DL; Chew DP; Reginelli J; Schneider JP; Topol EJ; Ellis SG
    Circulation; 2003 Apr; 107(13):1750-6. PubMed ID: 12665489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprocedural statin use in patients undergoing percutaneous coronary intervention.
    Kenaan M; Seth M; Aronow HD; Naoum J; Wunderly D; Mitchiner J; Moscucci M; Gurm HS;
    Am Heart J; 2014 Jul; 168(1):110-6.e3. PubMed ID: 24952867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
    Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP;
    J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of oral beta-blocker therapy on mortality after primary percutaneous coronary intervention for Killip class 1 myocardial infarction.
    Hioki H; Motoki H; Izawa A; Kashima Y; Miura T; Ebisawa S; Tomita T; Miyashita Y; Koyama J; Ikeda U
    Heart Vessels; 2016 May; 31(5):687-93. PubMed ID: 25863805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative statin therapy reduces mortality in normolipidemic patients undergoing cardiac surgery.
    Vaduganathan M; Stone NJ; Lee R; McGee EC; Malaisrie SC; Silverberg RA; Kansal P; McCarthy PM
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1018-27. PubMed ID: 20851427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuative statin therapy after percutaneous coronary intervention improves outcome in coronary bypass surgery: a propensity score analysis of 2501 patients.
    Mannacio V; Meier P; Antignano A; Mottola M; Di Tommaso L; Musumeci F; Vosa C
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1876-83. PubMed ID: 24667027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.